Omega Healthcare Investors
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Omega Healthcare Investors generated cash of $617,736,000, which is less than the previous year. Cash used in financing activities reached the amount of -$473,310,000 last year. Net change in cash is therefore $144,086,000.
Cash Flow
| 2014 | 337.54M | -547.94M | 212.27M |
|---|---|---|---|
| 2015 | 463.88M | -397.41M | -65.31M |
| 2016 | 625.79M | -1.11B | 576.29M |
| 2017 | 577.91M | -285.13M | -303.81M |
| 2018 | 499.37M | -173.21M | -410.70M |
| 2019 | 553.74M | -378.95M | -153.95M |
| 2020 | 708.25M | -89.05M | -485.54M |
| 2021 | 722.13M | -524.17M | -341.11M |
| 2022 | 625.72M | 442.85M | -789.44M |
| 2023 | 617.73M | -770K | -473.31M |
OHI Cash Flow Statement (2014 β 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 300.64M | 24.41M | 167.55M | 33.38M | 11.67M | 96.80M | 107.27M | 5.42M | 4.48M | 2.61M |
Operating activities | ||||||||||
Net income | 248.79M | 438.84M | 428.30M | 163.54M | 351.94M | 293.88M | 104.91M | 383.36M | 233.31M | 221.34M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 319.68M | 332.40M | 342.01M | 329.92M | 301.68M | 281.27M | 287.59M | 267.06M | 210.70M | 123.25M |
Stock-based compensation expense | 35.06M | 27.30M | 21.41M | 18.82M | 15.35M | 15.98M | 15.21M | 13.79M | 11.13M | 8.59M |
| Deferred income tax benefit | 35.06M | 27.30M | 21.41M | 18.82M | 15.35M | 15.98M | 15.21M | 13.79M | 11.13M | 8.59M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | -58.01M | -75.37M | -23.25M | -52.51M | -59.19M | -61.86M | -46.96M | -35.80M | -23.22M |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | 617.73M | 625.72M | 722.13M | 708.25M | 553.74M | 499.37M | 577.91M | 625.79M | 463.88M | 337.54M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -619.21M | -164.79M | -167.93M | -100.31M | -385.70M | -139.04M | -271.55M | -65.40M | -9.44M |
Investments In Property Plant And Equipment | 0 | -47.22M | -95.06M | -75.11M | -139.67M | -139.44M | -86.68M | -68.98M | -164.22M | 0 |
Acquisitions Net | -12.35M | -113K | -16.21M | -10.02M | -163.57M | 201.09M | 2.34M | -50.03M | 84.85M | 0 |
Cash generated by investing activities | -770K | 442.85M | -524.17M | -89.05M | -378.95M | -173.21M | -285.13M | -1.11B | -397.41M | -547.94M |
Financing activities | ||||||||||
Common Stock Issued | 336.40M | 8.11M | 274.01M | 152.78M | 515.35M | 0 | 22.12M | 0 | 439.32M | 61.98M |
Payments for dividends | -643.86M | -632.89M | -637.64M | -612.31M | -564.12M | -528.69M | -502.60M | -453.15M | -358.23M | -258.50M |
Repurchases of common stock | 0 | -142.26M | -79K | 1.84B | 0 | 0 | -48K | 0 | 0 | 1.73B |
Repayments of term debt | -227.91M | 8.11M | -96.81M | -1.83B | -79.33M | -20.95M | 193.96M | 826.92M | -204.19M | -1.38B |
Cash used in financing activities | -473.31M | -789.44M | -341.11M | -485.54M | -153.95M | -410.70M | -303.81M | 576.29M | -65.31M | 212.27M |
Net Change In Cash | 144.08M | 276.23M | -143.14M | 134.17M | 21.70M | -85.13M | -10.46M | 88.26M | 935K | 1.87M |
Cash at end of period | 444.73M | 300.64M | 24.41M | 167.55M | 33.38M | 11.67M | 96.80M | 93.68M | 5.42M | 4.48M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |